BETHLEHEM, Pa., Feb. 22, 2011 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) announced today that its OraQuick ® HCV Rapid Antibody Test has now been approved by the U.S. Food and Drug ...
OraSure Initiates Enrollment in Final Clinical Study for OraQuick(R) Rapid HIV Over-the-Counter Test
BETHLEHEM, Pa., Dec. 13, 2010 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR), the market leader in oral fluid diagnostics, announced today that it has enrolled the first subject in its ...
The test stick is swabbed along the upper and lower gum once and placed into the test tube for 20 minutes before reading the results. The Food and Drug Administration (FDA) has expanded the approval ...
OraQuick HIV Self-Test that will increase access to HIV testing for adolescents. The change expands the approved age range to include individuals 14 years of age and older for the OraQuick HIV ...
BETHLEHEM, Pa. - The product that put OraSure on the map more than two decades ago is expanding its reach. On Tuesday the Bethlehem-based maker of at-home diagnostic tests announced that its OraQuick ...
BETHLEHEM, Pa., Feb. 10, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OraSure”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today ...
BETHLEHEM, Pa., Jan. 07, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Tuesday, January 7th by OraSure Technologies, Inc. (NASDAQ: OSUR), please note that the first sentence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results